<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To compare levels of beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies with six different <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) in sera from patients with certain adverse pregnancy conditions </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: aPL levels were examined in pregnant women with anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome (26), pre-<z:hpo ids='HP_0100601'>eclampsia</z:hpo> (32), <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> (12), or <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (23) and in a group with physiological pregnancy (38) </plain></SENT>
<SENT sid="2" pm="."><plain>A commercial ELISA was used to determine the serum levels of anti-beta2-GPI (Immunotech) in isotypes IgG and IgA, and anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> levels (Milenia) in IgG and IgM </plain></SENT>
<SENT sid="3" pm="."><plain>aPL screening also included L-alpha-<z:chebi fb="0" ids="16337">phosphatidic acid</z:chebi>, L-alpha-<z:chebi fb="0" ids="16038">phosphatidylethanolamine</z:chebi>, L-alpha-<z:chebi fb="0" ids="26025">phosphatidyl</z:chebi>-DL-<z:chebi fb="3" ids="17754">glycerol</z:chebi>, L-alpha-phosphatidylinositol, and L-alpha-<z:chebi fb="0" ids="26025">phosphatidyl</z:chebi>-serine (Sigma, U.S.A.) in IgG and IgM </plain></SENT>
<SENT sid="4" pm="."><plain>Statistical analysis of <z:hpo ids='HP_0000001'>all</z:hpo> aPL levels was made by cut-off levels for Ig isotypes by using 3 SD or 95th percentile calculated using STATGRAPHICS </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Positive levels of antibodies against beta2-GPI in IgA are more frequently associated with a diagnosis of anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome, pre-<z:hpo ids='HP_0100601'>eclampsia</z:hpo>, and <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> in pregnant women than with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> in pregnancy </plain></SENT>
<SENT sid="6" pm="."><plain>Very high interindividual differences in aPLs (against <z:chebi fb="1" ids="24848">inositol</z:chebi>, <z:chebi fb="0" ids="17115,29999">L-serine</z:chebi>, <z:chebi fb="0" ids="28494">cardiolipin</z:chebi>, and beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> in IgG and IgA) were found in serum from women with pregnancy complicated by anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> syndrome, pre-<z:hpo ids='HP_0100601'>eclampsia</z:hpo>, and <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Pregnant patients with <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> had higher serum levels in aPLs to DL-<z:chebi fb="3" ids="17754">glycerol</z:chebi>, <z:chebi fb="1" ids="24848">inositol</z:chebi>, <z:chebi fb="0" ids="17115,29999">L-serine</z:chebi>, and beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>Positive aPL levels predominate in isotype IgG </plain></SENT>
<SENT sid="9" pm="."><plain>Very low levels of aPLs to <z:chebi fb="0" ids="16337">phosphatidic acid</z:chebi> and <z:chebi fb="0" ids="26025">phosphatidyl</z:chebi>-<z:chebi fb="0" ids="16000,23981">ethanolamine</z:chebi> were detected in <z:hpo ids='HP_0000001'>all</z:hpo> groups studied </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Serum levels of anti-beta2-GPI could serve as a better prognostic marker in <z:e sem="disease" ids="C0032962" disease_type="Disease or Syndrome" abbrv="">complicated pregnancy</z:e> than the panel of seven different anti-<z:chebi fb="0" ids="16247">phospholipid</z:chebi> antibodies </plain></SENT>
<SENT sid="11" pm="."><plain>Detection of anti-beta2-GPI is proposed as a first step of the screening for aPLs </plain></SENT>
</text></document>